Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > New Technique Detects Trace Levels of New Class of Cancer Biomarkers

Abstract:
In less than a decade, a new type of RNA — microRNA (miRNA) — has gone from curiosity to one of the most important sets of regulatory molecules in the body. And because these short pieces of RNA are associated with specific tissues and functions, and because they circulate stably in the bloodstream, they have great potential as diagnostic biomarkers for cancer and other diseases. The major obstacle to realizing that potential is that miRNAs are present in blood at levels too low to detect reliably with today's applicable biomolecular detection technology.

New Technique Detects Trace Levels of New Class of Cancer Biomarkers

Bethesda, MD | Posted on May 14th, 2012

That obstacle is no more. A team of investigators from the Northwestern University Center for Cancer Nanotechnology Excellence (Northwestern CCNE) has developed a rapid, array-based technology using gold nanoparticles that is capable of detecting miRNAs at levels as low as 1 femtomolar (about 30,000 molecules in a drop of blood). In contrast, standard fluorescence-based detection schemes are unable to detect 88 percent of the miRNAs in blood at concentrations 10 times higher than the limit of detection of the new assay. The Northwestern CCNE team, led by Chad Mirkin and Shad Thaxton, published the details of their new assay in the journal Analytical Chemistry.

The new assay, which the researchers call the Scanometric miRNA platform, can detect hundreds to thousands of miRNAs simultaneously. After isolating miRNA from human blood or a tissue sample, the Northwestern CCNE team uses an enzyme to attach a universal linker to every molecule of miRNA. They then add the modified miRNA mixture to an array comprising individual spots of DNA, each of which is designed to bind to a known miRNA sequence. After allowing the miRNAs in the sample to bind to their particular spot on the array, the investigators wash the array to remove unbound miRNAs and then treat it with the key reagent - a spherical nucleic acid-gold nanoparticle conjugate that binds very tightly to the universal linker that had been added to the miRNA mixture. Finally, the array is treated with a solution that adds an extra shell of gold onto the bound spherical nucleic acid-gold nanoparticles. This last step enhances the nanoparticle's ability to scatter light and greatly increases the assay's sensitivity. The treated array is then imaged with a commercial array scanner.

To test the performance of their system, the Northwestern CCNE team used their array to detect miRNAs isolated from prostate cancer cells. The Scanometric miRNA platform 88 percent more miRNAs than did the standard fluorescence-based assays now used to measure miRNA content in biological samples. The team then used their assay to detect miRNAs from human prostate cancer tissue samples and found distinct differences between tissue samples obtained from slow-growing versus aggressive prostate cancers, and were able to identify the aggressive tumors with 98.8 percent accuracy.

Further analysis of the data revealed a small set of miRNAs that appear to be deregulated and may play a role in the progression of prostate cancer. Some of these miRNAs may prove to be useful as novel biomarkers for prostate cancer, though the investigators note that a larger clinical trial is needed to confirm this finding.

This work, which is detailed in a paper titled, "Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugates," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. An abstract of this paper is available at the journal's website.

####

About The National Cancer Institute (NCI)
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.

The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © The National Cancer Institute (NCI)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - "Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid–gold nanoparticle conjugates."

Related News Press

News and information

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Exotic insulator may hold clue to key mystery of modern physics: Johns Hopkins-led research shows material living between classical and quantum worlds December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Discoveries

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project